Global Bone Growth Stimulator Market Report and Forecast 2023-2031
Global Bone Growth Stimulator Market Outlook
The global bone growth stimulator market value was USD 1.70 billion in 2022, driven by the increasing prevalence of orthopaedic conditions across the globe. The global market share is anticipated to grow at a CAGR of 5.4% during the forecast period of 2023-2031 to achieve a value of USD 2.73 billion by 2031.
Bone Growth Stimulator: Introduction
Bone growth stimulators are medical devices that help promote the healing of fractures and spinal fusion by stimulating the body's natural bone growth processes. These devices use techniques such as electrical stimulation, ultrasound, or magnetic fields to promote bone healing.
Bone Growth Stimulator Market Scenario
The global bone growth stimulator market has witnessed significant growth in recent years, driven by factors such as the increasing prevalence of orthopaedic conditions, the aging population, and advancements in bone growth stimulation technologies.
North America: The largest market for bone growth stimulators, driven by factors such as advanced healthcare infrastructure, high prevalence of orthopaedic conditions, and significant investments in research and development.
Europe: The second-largest market, with increasing demand for bone growth stimulators due to a growing aging population, a supportive regulatory framework, and an expanding healthcare sector.
Asia-Pacific: Expected to witness the highest growth rate due to factors such as a rapidly growing population, increasing prevalence of orthopaedic conditions, and growing investments in healthcare infrastructure and research.
Bone Growth Stimulator Market Segmentations
Market Breakup by Type
Bone Growth Stimulation Devices
External BGS
Implanted BGS
Ultrasonic BGS
Bone Morphogenetic Proteins (BMP)
Platelet-Rich Plasma
Market Breakup by Application
Spinal Fusion Surgeries
Delayed Union and Non-union Bone Fractures
Oral and Maxillofacial Surgeries
Others
Market Breakup by End Use
Hospitals and Clinics
Home Care
Academics and Research Institutes and CROS
Market by Region
North America
United States of America
Canada
Europe
United Kingdom
Germany
France
Italy
Others
Asia Pacific
China
Japan
India
ASEAN
Australia
Others
Latin America
Brazil
Argentina
Mexico
Others
Middle East and Africa
Saudi Arabia
United Arab Emirates
Nigeria
South Africa
Others
Key Trends in the Bone Growth Stimulator Market
Some key trends of the market are as follows:
Increasing prevalence of orthopaedic conditions: The rising incidence of conditions such as osteoporosis, spinal disorders, and fractures has led to a growing demand for bone growth stimulators, driving market growth.
Aging population: The growing aging population worldwide has increased the risk of bone-related issues and fractures, further contributing to the demand for bone growth stimulators.
Advancements in bone growth stimulation technologies: The development of new and more effective bone growth stimulation techniques and devices has improved the efficiency and safety of these treatments, further driving market growth.
Competitor Landscape
The report gives an in-depth analysis of the key players involved in the bone growth stimulator market, sponsors manufacturing the drugs, and putting them through trials to get FDA approvals. The companies included in the market are as follows:
Medtronic
Bioventus LLC
Orthofix Holdings, Inc.
Zimmer Biomet Holdings Inc.
DJO, LLC
DePuy Synthes
Stryker Corporation
Arthrex, Inc.
Bioventus
Isto Biologics
Terumo BCT, Inc.
*Please Note:* The report will be completed in 7 business days after order confirmation
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Bone Growth Stimulator Market Overview
3.1 Global Bone Growth Stimulator Market Historical Value (2016-2022)
3.2 Global Bone Growth Stimulator Market Forecast Value (2023-2031)
4 Global Bone Growth Stimulator Market Landscape
4.1 Global Bone Growth Stimulator Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Bone Growth Stimulator Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Applications
4.2.3 Analysis by End User
5 Global Bone Growth Stimulator Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Bone Growth Stimulator Market Segmentation
6.1 Global Bone Growth Stimulator Market by Type
6.1.1 Market Overview
6.1.2 Bone Growth Stimulation Devices
6.1.2.1 External BGS
6.1.2.2 Implanted BGS
6.1.2.3 Ultrasonic BGS
6.1.3 Bone Morphogenetic Proteins (BMP)
6.1.4 Platelet-Rich Plasma
6.2 Global Bone Growth Stimulator Market by Application
6.2.1 Market Overview
6.2.2 Spinal Fusion Surgeries
6.2.3 Delayed Union and Non-union Bone Fractures
6.2.4 Oral and Maxillofacial Surgeries
6.2.5 Others
6.3 Global Bone Growth Stimulator Market by End Use
6.3.1 Market Overview
6.3.2 Hospitals and Clinics
6.3.3 Home Care
6.3.4 Academics and Research Institutes and CROS
6.4 Global Bone Growth Stimulator Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Bone Growth Stimulator Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Bone Growth Stimulator Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Bone Growth Stimulator Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Bone Growth Stimulator Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Bone Growth Stimulator Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Medtronic
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Bioventus LLC
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Orthofix Holdings, Inc.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Zimmer Biomet Holdings Inc.
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 DJO, LLC
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 DePuy Synthes
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Stryker Corporation
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Arthrex, Inc.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Bioventus
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Isto Biologics
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Terumo BCT, Inc.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
18 Global Bone Growth Stimulator Market- Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment